Herpes zoster virus of shingles
About us We are a science-led global healthcare company with a special purpose: to help people do more, feel better, live longer.
Read morePress releases
- ViiV Healthcare presents positive 96-week data from phase III study of investigational fostemsavir in heavily treatment-experienced patients with HIV at IAS 2019
- IAS 2019: ViiV Healthcare showcasing innovation in HIV science
- GSK announces positive headline results in Phase 3 PRIMA study of ZEJULA (niraparib) for patients with ovarian cancer in the first line maintenance setting
Tweets from GSK
-
GSK @GSK
Find out more about our new approach to drug research and development as @SarahNev interviews Hal Barron, our Chief Scientific Officer and President, R&D in @FT (sub req) twitter.com/FT/status/1152…
about 6 hours ago
-
GSK @GSK
#FlashbackFriday to this time 50 years ago when the #Apollo11 mission headed to the moon. #DYK that some of our heritage medicines were on board? The astronauts carried tablets for travel sickness! #Apollo50th
about 3 days ago
-
GSK @GSK
Go #BehindTheScience with @ViiVHC to find out what they have planned for #IAS2019 - the world’s largest open scientific conference on #HIV science: gsk.to/2SpTO5b twitter.com/ViiVHC/status/…
about 3 days ago
